$6.6million as of march.
this trial isnt expensive vs other biotechs at all.
Also these options expiring December this year is another 2.1million that should come in before December.
Would expect conversion after kick off off phase 3, and share pirce comfortably back at 30c etc.
So yes their may be a cap raise soon, but literally at our lowest point equal to start of 2021.....it would be attractive for an investor but shitty for dilution and not required right now. I would expect end of Q3 on the back of trial starts, but prior to trial results, read outs etc.?
- Forums
- ASX - By Stock
- EMD
- general talk
general talk, page-19
-
- There are more pages in this discussion • 339 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.46M |
Open | High | Low | Value | Volume |
2.9¢ | 3.1¢ | 2.9¢ | $13.55K | 449.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 98317 | 2.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 19900 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 98317 | 0.029 |
3 | 72500 | 0.028 |
2 | 300000 | 0.027 |
1 | 384615 | 0.026 |
6 | 628499 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 19900 | 1 |
0.032 | 154301 | 1 |
0.034 | 38800 | 2 |
0.035 | 143664 | 3 |
0.038 | 53000 | 2 |
Last trade - 15.31pm 10/10/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online